Skip to content
Open menu Close menu

Dr Venu Vangala

PositionLecturer in Medicines Development and Pharmaceutical Science
Location3.16 Norcroft building
DepartmentBradford School of Pharmacy
RKT CentrePharmaceutical Engineering
Telephone+44 (0) 1274 236116
LinkedInVisit my LinkedIn profile

Research Interests (key words only)

Crystal Engineering, Pharmaceutical Technology, Pharmaceutical Solids, Co-crystals, Polymorphism, Pre-formulation, X-Ray Diffraction

Teaching and Supervisory Responsibilities

Undergraduate: MPharm ('Team Based Learning' environment)

  • Year 1 Personal Academic Tutor
  • Year 2 Urinary System 1&2 (Unit Lead)
  • Year 2 Liver and Drug Metabolism
  • Year 3 Gastrointestinal Problems 1&2

Postgraduate: MSc Pharmaceutical Technology


Venu Vangala joined as Lecturer in Medicines Development and Pharmaceutical Sciences. His research work focuses on building strong capability in interdisciplinary areas of fundamental and applied solid-state pharmaceuticals and pharmaceutical technology. Currently, he is involved in industrial collaborative projects with Advanced Extrusion Technology and N4 Pharma Ltd., UK.

Study History

  • Bachelor of Science, Kakatiya University, India
  • Master of Science (Chemistry), Kakatiya University, India
  • PhD (Crystal Engineering), University of Hyderabad, India

Professional History

  • 2014 – present: Lecturer in Medicines Development and Pharmaceutical Sciences
  • 2009 – 2014: Scientist, Institute of Chemical and Engineering Sciences, A*STAR, Singapore
  • 2007 – 2009: Post-Doctoral Fellow, University of Minnesota, USA
  • 2005 – 2007: Post-Doctoral Fellow, University of Iowa, USA

Professional Activities

Member of:

  • American Association of Pharmaceutical Scientists
  • Royal Society of Chemistry (e-membership)

Research Areas

  • Crystal engineering for the development of functional pharmaceutical materials
  • Solid state pharmaceuticals – cocrystals, polymorphs, salts and amorphous materials
  • Physicochemical characterization of pharmaceutical solids
  • Develop understanding of crystal structure vs pharmaceutical properties

Current Projects

Screening and characterization of novel co-crystals involving active pharmaceutical ingredients.

Research Collaborations

University of Minnesota, IISER Kolkata, University of Lucknow, University of Iowa.


  • Vangala VR, Chow PS, Reginald TBH, The solvates and a salt of an antibiotic agent, nitrofurantoin: Structural, thermochemical and desolvation studies. CrystEngComm 2013, 15, 878-889
  • Vangala VR, Chow PS, Reginald TBH, Co-crystals and co-crystal hydrates of the antibiotic nitrofurantoin: Structural and Physicochemical properties. Cryst. Growth Des. 2012, 12, 5925-5938
  • Aitipamula S, Vangala VR, Chow PS, Reginald TBH, A cocrystal hydrate of an antifungal agent, griseofulvin, with promising physicochemical properties. Cryst. Growth Des. 2012, 12, 5858-5863
  • A multi-author perspective: Desiraju GR, Karpinski P, Thaper RK, Zaworotko MJ, Vangala VR, and co-workers, Polymorphs, Salts, and Cocrystals: What's in a Name? Cryst. Growth Des. 2012, 12, 2147-2152
  • Vangala VR, Chow PS, Reginald TBH, Characterization, physicochemical and photo-stability of a co-crystal involving an antibiotic drug, nitrofurantoin, and 4-hydroxybenzoic acid. CrystEngComm 2011, 13, 759-762
  • Kaushal A, Vangala VR, Suryanarayanan R, Unusual effect of water vapour pressure on dehydration of dibasic calcium phosphate dihydrate, J. Pharm. Sci., 2011, 100, 1456-1466
  • Velaga S, Vangala VR, Srinivas B, Boström D, Polymorphism in acesulfame sweetener: structure–property and stability relationships of bending and brittle crystals, Chem. Commun., 2010, 46, 3562-3564

Share this